CF patients
F508del patients
PRO-CF-MED project
clinical assessment of QR
Cystic fibrosis-F508del MEDication Cystic fibrosis
life threatening F508del mutation
potential clinical efficacy of QR
clinical practice
clinical trials
innovative disease
Clinical Proof of concept
oligonucleotide-based treatment
palliative treatment
absence of CFTR
fast translation of QR
cystic fibrosis transmembrane conductance regulator
dysfunctional CFTR protein
progressive life
gene
vital organs
severe symptoms
viscous mucus
dramatic decrease
chloride efflux
plasma membrane
RNA
promising preclinical evidence
lungs
specific challenge
intestines
life-threatening condition
market authorisation
mutations
Partners